Viramatix Ltd is a discovery stage bio-pharmaceutical company, involved in the development of peptide based therapeutics against infectious diseases of unmet medical need. We seek to innovate in the areas of anti-viral, anti-bacterial and anti-fungal therapeutics development.
View Top Employees from VIRAMATIX LTDWebsite | http://www.viramatix.com |
Revenue | $3 million |
Employees | 1 (1 on RocketReach) |
Founded | 2017 |
Address | 71-75 Shelton St, London, Greater London WC2H 9JQ, GB |
Technologies |
JavaScript,
HTML,
Google Analytics
+6 more
(view full list)
|
Industry | Biotechnology, Manufacturing General, Manufacturing, Science and Engineering, Life Science, Pharmaceutical, Health Care |
SIC | SIC Code 21 Companies, SIC Code 20 Companies |
NAICS | NAICS Code 3122 Companies, NAICS Code 312 Companies, NAICS Code 31 Companies, NAICS Code 33 Companies |
Looking for a particular VIRAMATIX LTD employee's phone or email?
The VIRAMATIX LTD annual revenue was $3 million in 2024.
Adlan Hercus is the Chief Strategy Officer of VIRAMATIX LTD.
1 people are employed at VIRAMATIX LTD.
VIRAMATIX LTD is based in London, Greater London.
The NAICS codes for VIRAMATIX LTD are [3122, 312, 31, 33].
The SIC codes for VIRAMATIX LTD are [21, 20].